Repository NIGMS Human Genetic Cell Repository
Subcollection Human Variation
Pharmacogenetics
GeT-RM Samples
dbGaP
Alternate IDs GM14655 [HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)]
Quantity 50 µg
Quantitation Method Please see our FAQ
Biopsy Source Peripheral vein
Cell Type B-Lymphocyte
Tissue Type Blood
Transformant Epstein-Barr Virus
Species Homo sapiens
Common Name Human
Remarks Donor subject is heterozygous for a 1 bp deletion at nucleotide 1795 (1795delT) in exon 3 of the CYP2D6 gene (CYP2D6*6) which results in a premature stop codon
IDENTIFICATION OF SPECIES OF ORIGIN Species of Origin Confirmed by Nucleoside Phosphorylase,Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis
 
Pharmacogenomics Panel For pharmacogenetic variants please click here: Pharmacogenomics Panel
 
Gene CYP2D6
Chromosomal Location 22q13.1
Allelic Variant 1 124030.0003; DEBRISOQUINE, POOR METABOLISM OF
Identified Mutation 1-BP DEL, 1707T; This allelic variant is also known as CYP2D6*6 or CYP2D6(T). In individuals with the PM phenotype (608902), Saxena et al. (Hum Molec Genet 3:923-926, 1994) identified a single base deletion in exon 3 of the CYP2D6 gene, removing thymine-1795 and resulting in a premature stop codon. They designated the allele CYP2D6(T). Among Caucasian controls, the frequency of the 2D6(T) allele was 1.8% (4/220 chromosomes).
Remark Donor subject is heterozygous for a 1 bp deletion at nucleotide 1795 (1795delT) in exon 3 of the CYP2D6 gene (CYP2D6*6) which results in a premature stop codon
Yousaf R, Ahmed ZM, Giese AP, Morell RJ, Lagziel A, Dabdoub A, Wilcox ER, Riazuddin S, Friedman TB, Riazuddin S, Modifier variant of METTL13 suppresses human GAB1-associated profound deafness The Journal of clinical investigation: 2018
PubMed ID: 29408807
 
Pratt VM, Zehnbauer B, Wilson JA, Baak R, Babic N, Bettinotti M, Buller A, Butz K, Campbell M, Civalier C, El-Badry A, Farkas DH, Lyon E, Mandal S, McKinney J, Muralidharan K, Noll L, Sander T, Shabbeer J, Smith C, Telatar M, Toji L, Vairavan A, Vance C, Weck KE, Wu AH, Yeo KT, Zeller M, and Kalman L., Characterization of 107 Genomic DNA Reference Materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1 J Mol Diagn12(6):835-46 2010
PubMed ID: 20889555
 
Lee CC, McMillin GA, Babic N, Melis R, Yeo KT, Evaluation of a CYP2C19 genotype panel on the GenMark eSensor® platform and the comparison to the Autogenomics Infiniti™ and Luminex CYP2C19 panels Clinica chimica acta; international journal of clinical chemistry412(11-12):133-7 2010
PubMed ID: 21385571
 
Marini NJ, Gin J, Ziegle J, Keho KH, Ginzinger D, Gilbert DA, Rine J, The prevalence of folate-remedial MTHFR enzyme variants in humans Proceedings of the National Academy of Sciences of the United States of America412(11-12):133-7 2008
PubMed ID: 18523009
 
Melis, R., Lyon, E., and McMillin, G.A., Determination of CYP2D6, CYP2C9 and CYP2C19 genotypes with Tag-It mutation detection assays Expert Rev Mol Diagn6(6):811-20 2006
PubMed ID: 17140368
No data is available
Split Ratio 1:2
Temperature 37 C
Percent CO2 5%
Percent O2 AMBIENT
Medium Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent
Serum 15% fetal bovine serum Not Inactivated
Substrate None specified
Subcultivation Method dilution - add fresh medium